Presentation TCT 2024 TCT 767: The Clinical Impact of Nicorandil Treatment on the Top of Standard Anti-Anginal Medications in Patients With Significant Coronary Artery Spasm up to 5 Years Presenter: Woo Jin Ahn October 30, 2024
Presentation TCT 2024 TCT 764: Clinical Outcomes of High Intensity Lipid Lowering Therapy in Patient Following Complex PCI Presenter: Young-Kwan Kim October 30, 2024
Presentation TCT 2024 Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR) Presenter: Allan Schwartz October 30, 2024
Presentation TCT 2024 Keynote Lecture II: Master Clinician Perspectives: How Will the Recent Evidence Impact Guidelines and Clinical Practice? Presenter: Patrick O'Gara October 30, 2024
Presentation TCT 2024 A Critical Review of Clinical Results in Current TMVR Trials: Implications for Patient Selection and Study Design Presenter: Firas Zahr October 30, 2024
Presentation TCT 2024 Welcome, Clinical Rationale of Bioadaptive PCI Presenter: Dean Kereiakes October 30, 2024
Presentation TCT 2024 Overview of Clinical Data on TAVR in BAVD – Is an RCT Needed? Presenter: Yousif Ahmad October 30, 2024
Presentation TCT 2024 Transcatheter Repair Versus Surgery in Atrial Mitral Regurgitation: Results From the MATTERHORN Trial Presenter: Stephan Baldus October 30, 2024
Presentation TCT 2024 Variations in New Clinical Trial Designs for Emerging CEP Devices Presenter: Alexandra Lansky October 30, 2024
Presentation TCT 2024 DANGER Shock: Impella versus Standard Card for STEMI Patients with Cardiogenic Shock Presenter: Jacob Moeller October 30, 2024
Presentation TCT 2024 CLASP IID Randomized Trial and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation Presenter: Firas Zahr October 30, 2024
Presentation TCT 2024 Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: The CLEAR IE Multicenter Registry Presenter: Abdallah El Sabbagh October 30, 2024
Presentation TCT 2024 The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System Presenter: Olivier Bertrand October 30, 2024
Presentation TCT 2024 3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial Presenter: Hongbo Yang October 30, 2024